Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01419613 · ClinicalTrials.gov registry record · NA

Promoting a Healthier Lifestyle Among Breast Cancer Survivors

A NA study of Breast Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT01419613: Completed NA study of Breast Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT01419613 is a NA study of Breast Cancer that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 68 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01419613, a NA study of Breast Cancer, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out if a counseling program the investigators have developed can help breast cancer survivors adopt a healthier lifestyle.

Primary Outcome

The primary objective of this study is to evaluate the efficacy of a brief Motivational Interviewing (MI) based intervention, relative to a time and attention control intervention (healthy lifestyle counseling), in promoting physical activity among early-stage breast cancer survivors who are physically inactive but are contemplating increasing their level of physical activity.

Conditions Studied

Interventions

  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL Counseling

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2010-08
Est. Completion 2015-05
Phase NA

What the finished NCT01419613 record still lists

NCT01419613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing is the first listed.

NCT01419613 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01419613 about?

NCT01419613 is a clinical study titled "Promoting a Healthier Lifestyle Among Breast Cancer Survivors". The purpose of this study is to find out if a counseling program the investigators have developed can help breast cancer survivors adopt a healthier lifestyle.

What is the current status of trial NCT01419613?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2010-08. Estimated completion is 2015-05.

What conditions does trial NCT01419613 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01419613?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01419613?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01419613 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01419613's enrollment target sits among peer trials

68 706th of 1224 higher than 509 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01419613, the US trial registry maintained by the National Library of Medicine. NCT01419613 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.